Ionis Pharmaceuticals Inc (IONS)
41.07
+0.39
(+0.96%)
USD |
NASDAQ |
Apr 22, 16:00
41.09
+0.02
(+0.05%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Investing (TTM): -214.13M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -214.13M |
| September 30, 2023 | 24.73M |
| June 30, 2023 | -227.91M |
| March 31, 2023 | -300.73M |
| December 31, 2022 | -262.64M |
| September 30, 2022 | -379.67M |
| June 30, 2022 | -73.77M |
| March 31, 2022 | -171.50M |
| December 31, 2021 | 194.91M |
| September 30, 2021 | 287.65M |
| June 30, 2021 | 267.62M |
| March 31, 2021 | 448.34M |
| December 31, 2020 | 274.48M |
| September 30, 2020 | 224.82M |
| June 30, 2020 | 124.28M |
| March 31, 2020 | -66.11M |
| December 31, 2019 | -41.27M |
| September 30, 2019 | -505.67M |
| June 30, 2019 | -814.74M |
| March 31, 2019 | -1.079B |
| December 31, 2018 | -929.56M |
| September 30, 2018 | -657.57M |
| June 30, 2018 | -500.00M |
| March 31, 2018 | -110.13M |
| December 31, 2017 | -358.29M |
| Date | Value |
|---|---|
| September 30, 2017 | -283.28M |
| June 30, 2017 | -190.27M |
| March 31, 2017 | -151.50M |
| December 31, 2016 | 56.60M |
| September 30, 2016 | 63.76M |
| June 30, 2016 | 91.57M |
| March 31, 2016 | -57.27M |
| December 31, 2015 | -60.05M |
| September 30, 2015 | -138.80M |
| June 30, 2015 | -134.01M |
| March 31, 2015 | -71.02M |
| December 31, 2014 | -82.85M |
| September 30, 2014 | -117.33M |
| June 30, 2014 | -216.15M |
| March 31, 2014 | -215.60M |
| December 31, 2013 | -255.73M |
| September 30, 2013 | -165.42M |
| June 30, 2013 | -52.72M |
| March 31, 2013 | 3.215M |
| December 31, 2012 | 18.00M |
| September 30, 2012 | 45.33M |
| June 30, 2012 | 50.24M |
| March 31, 2012 | 50.79M |
| December 31, 2011 | 108.03M |
| September 30, 2011 | 68.41M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-814.74M
Minimum
Jun 2019
448.34M
Maximum
Mar 2021
-63.75M
Average
-66.11M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -502.52M |
| Viking Therapeutics Inc | -179.09M |
| Alnylam Pharmaceuticals Inc | -336.35M |
| Akero Therapeutics Inc | -223.62M |
| 89bio Inc | -123.02M |